Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Management of Myeloproliferative Neoplasms: A Focus on Polycythemia Vera and Myelofibrosis

EP. 1: Overview of Myeloproliferative Neoplasms

July 8th 2019

EP. 2: Differentiating Between Myeloproliferative Neoplasms

July 8th 2019

EP. 3: Diagnosing Polycythemia Vera

July 8th 2019

EP. 4: Suspecting Polycythemia Vera: Challenges in Diagnosis

July 8th 2019

EP. 5: Frontline Therapy for Polycythemia Vera

July 8th 2019

EP. 6: Treating Leukocytosis in Polycythemia Vera

July 8th 2019

EP. 7: Cytoreductive Therapy in Polycythemia Vera

July 8th 2019

EP. 8: Ruxolitinib for Treatment of Polycythemia Vera

July 8th 2019

EP. 9: RESPONSE-2 Trial: Ruxolitinib for PV

July 8th 2019

EP. 10: Interferon's Role in Treating Polycythemia Vera

July 8th 2019

EP. 11: Diagnosis and Risk Stratification in Myelofibrosis

July 8th 2019

EP. 12: Ruxolitinib's Role in Treating Myelofibrosis

July 8th 2019

EP. 13: COMFORT Ruxolitinib Studies for Myelofibrosis

July 8th 2019

EP. 14: Dosing of Ruxolitinib in PV and MF

July 8th 2019

EP. 15: Fedratinib in MF: JAKARTA2 and FREEDOM Trials

July 8th 2019

EP. 16: Emerging Agents Pacritinib and Momelotinib for MF

July 8th 2019

EP. 17: Other Pathways Studied for MF

July 8th 2019

EP. 18: Unmet Needs and Future Directions in Treating MPNs

July 8th 2019
Advertisement
Advertisement

Trending on OncLive

1

Patient-Level Data Show Extended OS Advantage With DCVax-L vs External Controls in Glioblastoma

2

Zoldonrasib Combinations Show Compelling Antitumor Activity in RAS G12D–Mutant Metastatic PDAC

3

Hematologists Detail Practice-Shaping Data That Emerged at EHA 2026 (VIDEO)

4

Ensartinib Reduces Recurrence Risk After Resection in ALK-Positive NSCLC

5

Novel Antibody-Drug Conjugate Eliminates Residual Cancer Cells in Majority of Patients With B-Cell ALL

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us